최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기한국콘텐츠학회논문지 = The Journal of the Korea Contents Association, v.20 no.10, 2020년, pp.401 - 410
옥종선 (건국대학교 간호학과)
This study is to conduct a 12-month f/u survey on changes of metabolic syndrome (MetS) components according to the resting heart rate (RHR) in patients with essential hypertension (HTN) without cardiovascular disease (CVD) complication. We used the KorHR (Korean Hypertension Registry) data and a tot...
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
핵심어 | 질문 | 논문에서 추출한 답변 |
---|---|---|
고혈압은 어떤 것으로 보고되는가? | 그리고 고혈압 환자에서 대사증후군의 유병률은 일반 인구 집단에 비해 더 높다[5]. 실제 고혈압은 대사증후군의 한 구성요소이기도 하며 고혈압 환자에서 대사증후군이 동반되어 있으면 고혈압성 표적 장기 손상의 발생이 가속화 되는 것으로 보고하고 있다[6]. 뿐만 아니라 대사증후군의 세부 요인의 수가 증가할수록 장기적인 심혈관계 질환의 발생 비율이 증가하는 것으로 보고하고 있다[7]. | |
초진과 재진 고혈압 환자에 따른 맞춤형 안정시심박수 조절을 위한 지침 마련과 안정시 심박수 조절을 위한 다양한 중재방안 마련이 필요한 이유는? | 본 연구는 일반인 인구 그룹보다 심혈관계 질환의 발생위험이 더욱 높은 고혈압 진단 환자를 대상으로 하였다. 특히 고혈압 환자를 초진과 재진 그룹으로 세분화 하여 안정시 심박수에 따른 대사증후군 세부 요인 변화를 관찰하였다는 점에서 다른 연구와의 차별성을 가진다. 본 연구결과 초진과 재진 고혈압 환자의 안정시 심박수 그룹에 따라 대사증후군 세부요인의 변화 및 대사증후군 세부요인 증가 위험이 다른 것으로 나타났다. 따라서 초진과 재진 고혈압 환자에 따른 맞춤형 안정시심박수 조절을 위한 지침 마련과 안정시 심박수 조절을 위한 다양한 중재방안 마련이 필요하다고 생각한다. | |
심혈관계 질환 합병증으로는 무엇이 포함되는가? | 심혈관계 질환 합병증으로는 허혈성 심장질환(협심증, 심근경색, 관상동맥 중재시술, 관상동맥 우회수술, 심부전), 뇌혈관 질환(일과성 뇌허혈, 허혈성 뇌졸중, 출혈성 뇌졸중, 경동맥 질환), 말초혈관질환(하지 파행, 하지혈관 중재시술, 사지 절단), 만성신장질환(신부전, 투석을 시행 받는 경우) 등이 포함된다. |
World Health Organization, World Health Statistics, 2010. https://www.who.int/gho/publications/world_health_statistics/EN_WHS10_Full.pdf?ua1
E. J. Benjamin, P. Muntner, and A. Alonso, "Heart Disease and Stroke Statistics-2019 Update: A Report from the American Heart Association," Circulation, Vol.139, No.10, pp.e56-e528, 2019.
Korean Statistics, "사망원인 통계," http://kosis.kr/statisticsList/statisticsListIndex.do?menuIdM_01_01&vwcdMT_ZTITLE&parmTabIdM_01_01, 2019.01.10.
S. E. Kjeldsen, l. Naditch-Brule, and S. Perlini, "Increased Prevalence of Metabolic Syndrome in Uncontrolled Hypertension across Europe: The Global Cardiometabolic Risk Profile in Patients with Hypertension Disease Survey," J Hypertens, Vol.26, No.10, pp.2064-2070, 2008.
G. Mule and G. Cerasola, "The Metabolic Syndrome and Its Relationship to Hypertensive Target Organ Damage," The Journal of Clinical Hypertension, Vol.8, No.3, pp.195-201, 2006.
C. Cuspidi, S. Meani, and C. Valerio, "Age and Target Organ Damage in Essential Hypertension: Role of the Metabolic Syndrome," American journal of hypertension, Vol.20, No.3, pp.296-303, 2007.
M. Mansourian, M. Babahajiani, and T. Jafari-Koshki, "Metabolic Syndrome Components and Long-Term Incidence of Cardiovascular Disease in Eastern Mediterranean Region: A 13-Year Population-Based Cohort Study," Metabolic syndrome and related disorders, Vol.17, No.7, pp.362-366, 2019.
W. B. Kannel, C. Kannel, and R. S. Paffenbarger Jr, "Heart Rate and Cardiovascular Mortality: The Framingham Study," American heart journal, Vol.113, No.6, pp.1489-1494, 1987.
E. Kristal-Boneh, H. Silber, and G. Harari, "The Association of Resting Heart Rate with Cardiovascular, Cancer and All-Cause Mortality. Eight Year Follow-up of 3527 Male Israeli Employees (the Cordis Study)," European heart journal, Vol.21, No.2, pp.116-124, 2000.
F. Seccareccia, F. Pannozzo, and F. Dima, "Heart Rate as a Predictor of Mortality: The Matiss Project," American journal of public health, Vol.91, No.8, pp.1258-1263, 2001.
K. Fox, I. Ford, and P. Steg, "Heart Rate as a Prognostic Risk Factor in Patients with Coronary Artery Disease and Left-Ventricular Systolic Dysfunction (Beautiful): A Subgroup Analysis of a Randomised Controlled Trial," The Lancet, Vol.372, No.9641, pp.817-821, 2008.
J. E. Ho, V. Bittner, and D. DeMicco, "Usefulness of Heart Rate at Rest as a Predictor of Mortality, Hospitalization for Heart Failure, Myocardial Infarction, and Stroke in Patients with Stable Coronary Heart Disease (Data from the Treating to New Targets [Tnt] Trial)," The American journal of cardiology, Vol.105, No.7, pp.905-911, 2010.
E. Oda and R. Kawai, "Significance of Heart Rate in the Prevalence of Metabolic Syndrome and Its Related Risk Factors in Japanese," Circ J, Vol.73, No.8, pp.1431-1436, 2009.
O. Rogowski, A. Steinvil, and S. Berliner, "Elevated Resting Heart Rate Is Associated with the Metabolic Syndrome," Cardiovasc Diabetol, Vol.8, No.55, pp.1-6, 2009.
H. I. Yang, H. C. Kim, and J. Y. Jeon, "The Association of Resting Heart Rate with Diabetes, Hypertension, and Metabolic Syndrome in the Korean Adult Population: The Fifth Korea National Health and Nutrition Examination Survey," Clin Chim Acta, No.455, pp.195-200, 2016.
P. Palatini, A. Benetos, and G. Grassi, "Identification and Management of the Hypertensive Patient with Elevated Heart Rate: Statement of a European Society of Hypertension Consensus Meeting," Journal of hypertension, Vol.24, No.4, pp.603-610, 2006.
H. Tomiyama, J. Yamada, and Y. Koji, "Heart Rate Elevation Precedes the Development of Metabolic Syndrome in Japanese Men: A Prospective Study," Hypertens Res, Vol.30, No.5, pp.417-426, 2007.
National Cholesterol Education Program Expert Panel on Detection, and Treatment of High Blood Cholesterol, "Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report," Circulation, Vol.106, No.25, pp.3143-3421, 2002.
Korean statistics, "만성질환," http://kosis.kr/statisticsList/statisticsListIndex.do?menuIdM_01_01&vwcdMT_ZTITLE&parmTabIdM_01_01, 2019.05.31.
V. Kontis, J. E. Bennett, and C. D. Mathers, "Projections of Life Expectancy in 35 Industrialised Countries: Projections with a Bayesian Model Ensemble," Lancet, Vol.389, No.10076, pp.1323-1335, 2017.
M. E. Levine, A. Harrati, and E. M. Crimmins, "Predictors and Implications of Accelerated Cognitive Aging," Biodemography and social biology, Vol.64, No.2, pp.83-101, 2018.
N. Chimanji, A. Kilic, and A. Hasan, "Institutional Cost Comparison between Heart Transplants and Left Ventricular Assist Device Implantations," Exp Clin Transplant, Vol.14, No.6, pp.656-659, 2016.
P. Palatini, L. Thijs, and J. A. Staessen, "Predictive Value of Clinic and Ambulatory Heart Rate for Mortality in Elderly Subjects with Systolic Hypertension," Archives of Internal Medicine, Vol.162, No.20, pp.2313-2321, 2002.
A. Hozawa, T. Ohkubo, and M. Kikuya, "Prognostic Value of Home Heart Rate for Cardiovascular Mortality in the General Population: The Ohasama Study," American journal of hypertension, Vol.17, No.11, pp.1005-1010, 2004.
T. Okamura, T. Hayakawa, and T. Kadowaki, "Resting Heart Rate and Cause-Specific Death in a 16.5-Year Cohort Study of the Japanese General Population," American heart journal, Vol.147, No.6, pp.1024-1032, 2004.
K. Fox, M. G. Bousser, and P. Amarenco, "Heart Rate Is a Prognostic Risk Factor for Myocardial Infarction: A Post Hoc Analysis in the Perform (Prevention of Cerebrovascular and Cardiovascular Events of Ischemic Origin with Terutroban in Patients with a History of Ischemic Stroke or Transient Ischemic Attack) Study Population," International journal of cardiology, Vol.168, No.4, pp.3500-3505, 2013.
M. Bohm, H. Schumacher, and K. K. Teo, "Resting Heart Rate and Cardiovascular Outcomes in Diabetic and Non-Diabetic Individuals at High Cardiovascular Risk Analysis from the Ontarget/Transcend Trials," European heart journal, Vol.41, No.2, pp.231-238, 2020.
E. M. Lonn, S. Rambihar, and P. Gao, "Heart Rate Is Associated with Increased Risk of Major Cardiovascular Events, Cardiovascular and All-Cause Death in Patients with Stable Chronic Cardiovascular Disease: An Analysis of Ontarget/Transcend," Clinical Research in Cardiology, Vol.103, No.2, pp.149-159, 2014.
G. Leonetti and C. G. Egan, "Use of Carvedilol in Hypertension: An Update," Vascular health and risk management, Vol.8, pp.307-322, 2012.
K. Ayers, L. M. Byrne, and A. DeMatteo, "Differential Effects of Nebivolol and Metoprolol on Insulin Sensitivity and Plasminogen Activator Inhibitor in the Metabolic Syndrome," Hypertension, Vol.59, No.4, pp.893-898, 2012.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.